Data presented today at the EuroPCR 2022 event supported the use of the Medtronic (NYSE:MDT) Resolute Onyx drug-eluting stent. University of Padua Medical School Head of Interventional Cardiology Dr. Giuseppe Tarantini presented late-breaking … [Read More...] about Medtronic’s Resolute Onyx drug-eluting stent demonstrates strong safety, efficacy
Main Content
Medical Tubing & Extrusion
Medtronic’s Resolute Onyx drug-eluting stent demonstrates strong safety, efficacy
Data presented today at the EuroPCR 2022 event supported the use of the Medtronic (NYSE:MDT) Resolute Onyx drug-eluting stent. University of Padua Medical School Head of Interventional Cardiology Dr. Giuseppe Tarantini presented late-breaking … [Read More...] about Medtronic’s Resolute Onyx drug-eluting stent demonstrates strong safety, efficacy
Avanos Medical recall of Cortrak 2 enteral access system is Class I
The FDA determined that Avanos Medical's recall of some of its Cortrak 2 enteral access systems is Class I, the most serious kind. Alpharetta, Georgia-based Avanos Medical is recalling certain Cortrak 2 general access systems due to reports of … [Read More...] about Avanos Medical recall of Cortrak 2 enteral access system is Class I
FDA approves Medtronic’s Onyx Frontier drug-eluting coronary stent
Medtronic (NYSE:MDT) announced today that it received FDA approval for its Onyx Frontier drug-eluting stent (DES). Onyx Frontier, the latest iteration of Medtronic’s Resolute DES family, was designed to leverage the same stent platform as Resolute … [Read More...] about FDA approves Medtronic’s Onyx Frontier drug-eluting coronary stent
Abbott announces availability of Xience Skypoint drug-eluting stent in extended sizes
Abbott (NYSE:ABT) announced today that its Xience Skypoint drug-eluting stent platform is now available globally. Xience Skypoint has received FDA approval, CE mark and PMDA approval in Japan for the broadest expansion with the availability of … [Read More...] about Abbott announces availability of Xience Skypoint drug-eluting stent in extended sizes
ICU Medical beats The Street in Q1
ICU Medical (Nasdaq:ICUI) reported first-quarter results that came in ahead of the consensus earnings per share forecast. The San Clemente, California-based company posted losses of $38.1 million, or $1.61 per share, on sales of $543.1 million for … [Read More...] about ICU Medical beats The Street in Q1
FDA warns of potential toxic risk from Fresenius hemodialysis machines
The FDA is evaluating the risk of exposure to toxic chemicals from silicone tubing used in Fresenius Medical Care (NYSE: FMS) hemodialysis machines. The investigation concerns three models of Fresenius hemodialysis machines: the 2008T, 2008K2, and … [Read More...] about FDA warns of potential toxic risk from Fresenius hemodialysis machines
Penumbra grows sales 20% in Q1
Penumbra (NYSE:PEN) this week posted first-quarter results that beat the revenue consensus on Wall Street but missed earnings estimates. The Alameda, California-based company reported profits of $79,000, or -1¢ per share, on sales of $203.9 … [Read More...] about Penumbra grows sales 20% in Q1
